RxDoctor Payments Data

Andrew Snider, PA

Physician Assistant · East Syracuse, NYNPI 1134597339

Payments from drug & device makers

$1,049in general payments, 2019–2025

Across 58 payments — averaging $18.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$208
  • Bayer$85
  • Exact Sciences$79
  • AbbVie$77
  • GSK$69
  • Lilly USA, LLC$65
  • plus $466 from 15 others

What the payments were for

  • Food & beverage$1,049100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,049 in reported general payments places this provider in the 75th percentile of 11,358 physician assistant providers in New York.

See all physician assistant providers in New York

Medicare billing

Part B allowed, 2024
$57,234
Medicare patients
164
Services billed
867

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide66$97,835
OzempicSemaglutide37$63,293
EliquisApixaban55$58,647
JardianceEmpagliflozin29$40,969
JanuviaSitagliptin Phosphate22$32,112
Trelegy ElliptaFluticasone/Umeclidin/Vilanter35$22,656
Soliqua 100-33Insulin Glargine/Lixisenatide11$22,012
InvokanaCanagliflozin12$18,885
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr17$10,520
Arnuity ElliptaFluticasone Furoate22$8,604
Breo ElliptaFluticasone/Vilanterol19$8,340
CreonLipase/Protease/Amylase11$8,121
Lantus SolostarInsulin Glargine,hum.Rec.Anlog28$5,685
Levothyroxine Sodium308$4,088
Atorvastatin Calcium363$3,725

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity$65$97,83566 claims
Novo NordiskOzempic$208$63,29337 claims
PfizerEliquis$45$58,64755 claims
GSKTrelegy Ellipta, Anoro Ellipta, Arnuity Ellipta, Breo Ellipta$69$50,12193 claims
Boehringer IngelheimJardiance$37$40,96929 claims
MerckJanuvia$24$32,11222 claims
Sanofi-aventis U.S. LLCSoliqua 100-33$26$22,01211 claims
AbbVieCreon, Synthroid$77$10,32444 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 11,358 physician assistant providers in New York.

Other physician assistant in East Syracuse

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →